Craig Hettenbach
Stock Analyst at Morgan Stanley
(0.33)
# 937
Out of 4,667 analysts
278
Total ratings
25%
Success rate
-23.15%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $101.55 | -4.48% | 14 | Nov 5, 2024 | |
| HCA HCA Healthcare | Initiates: Equal-Weight | $427 | $333.00 | +28.23% | 1 | Sep 3, 2024 | |
| ARDT Ardent Health Partners | Initiates: Overweight | $27 | $16.44 | +64.23% | 1 | Aug 12, 2024 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $9 → $5 | $4.10 | +21.95% | 12 | Aug 6, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $9.5 | $4.31 | +120.42% | 1 | Jun 10, 2024 | |
| VEEV Veeva Systems | Maintains: Underweight | $210 → $173 | $210.63 | -17.87% | 5 | May 31, 2024 | |
| AMWL American Well | Maintains: Equal-Weight | $35 → $20 | $7.84 | +155.10% | 4 | Apr 15, 2024 | |
| SWKS Skyworks Solutions | Maintains: Equal-Weight | $96 → $114 | $83.43 | +36.64% | 24 | Feb 7, 2023 | |
| ST Sensata Technologies Holding | Maintains: Overweight | $62 → $57 | $30.72 | +85.55% | 19 | Jun 10, 2022 | |
| MCHP Microchip Technology | Maintains: Overweight | $85 → $81 | $65.12 | +24.39% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $49.90 | -29.86% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.00 | +5.88% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $65.66 | +181.75% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $147.82 | +12.98% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $70.89 | -40.75% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $161.32 | -1.44% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $56.83 | +119.95% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $163.25 | -55.71% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $198.19 | -1.61% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $600.50 | -18.73% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $294.64 | +0.46% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $237.85 | +54.72% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $293.97 | +74.51% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $323.39 | -14.96% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $59.10 | +48.90% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $67.31 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $72.55 | +155.00% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $220.34 | -3.33% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $185.94 | -68.81% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $211.01 | -44.55% | 15 | Jun 16, 2020 |
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $101.55
Upside: -4.48%
HCA Healthcare
Sep 3, 2024
Initiates: Equal-Weight
Price Target: $427
Current: $333.00
Upside: +28.23%
Ardent Health Partners
Aug 12, 2024
Initiates: Overweight
Price Target: $27
Current: $16.44
Upside: +64.23%
Definitive Healthcare
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $4.10
Upside: +21.95%
GoodRx Holdings
Jun 10, 2024
Maintains: Equal-Weight
Price Target: $7 → $9.5
Current: $4.31
Upside: +120.42%
Veeva Systems
May 31, 2024
Maintains: Underweight
Price Target: $210 → $173
Current: $210.63
Upside: -17.87%
American Well
Apr 15, 2024
Maintains: Equal-Weight
Price Target: $35 → $20
Current: $7.84
Upside: +155.10%
Skyworks Solutions
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $83.43
Upside: +36.64%
Sensata Technologies Holding
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $30.72
Upside: +85.55%
Microchip Technology
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $65.12
Upside: +24.39%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $49.90
Upside: -29.86%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $17.00
Upside: +5.88%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $65.66
Upside: +181.75%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $147.82
Upside: +12.98%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $70.89
Upside: -40.75%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $161.32
Upside: -1.44%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $56.83
Upside: +119.95%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $163.25
Upside: -55.71%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $198.19
Upside: -1.61%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $600.50
Upside: -18.73%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $294.64
Upside: +0.46%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $237.85
Upside: +54.72%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $293.97
Upside: +74.51%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $323.39
Upside: -14.96%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $59.10
Upside: +48.90%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $67.31
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $72.55
Upside: +155.00%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $220.34
Upside: -3.33%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $185.94
Upside: -68.81%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $211.01
Upside: -44.55%